Web20 mrt. 2024 · Scotland has become the first country in the UK to approve a specific treatment for the hepatitis delta virus (HDV), after it granted bulevirtide (Hepcludex) “restricted use” approval for patients with chronic infection and compensated liver disease. 1 WebHepcludex is indicated for the treatment of chronic hepatitis delta virus (HDV) infection in plasma (or serum) HDV-RNA positive adult patients with compensated liver disease. It is …

Hepcludex European Medicines Agency

WebHepcludex’s RMP. I. The Medicine and What is it Used for Hepcludex is authorised for chronic hepatitis delta (CHD) – (see SmPC for the full indication). It contains bulevirtide as the active substance and it is given by subcutaneous injection. Further information about the evaluation of Hepcludex’s benefits can be found in Hepcludex’s WebHepcludex (bulevirtide) An overview of Hepcludex and why it is authorised in the EU . What is Hepcludex and what is it used for? Hepcludex is an antiviral medicine used to … spruit municipality address

First drug for hepatitis D has been approved by european …

WebIt has shown activity against the hepatitis B virus, and in July 2024 was approved by the European Commission for prescription in Europe, including Russia and the former Soviet Union, as the first effective hepatitis D drug in the world. In September 2024, it was launched in Germany, France, and Austria. Web25 jun. 2024 · Hepcludex (bulevirtide) – a first-in-class entry inhibitor developed by scientists at Heidelberg University in Germany – has already been granted a conditional … Web19 nov. 2024 · In Europe, Hepcludex ® (bulevirtide) has been granted Conditional Marketing Authorization by the European Commission and PRIority MEdicines (PRIME) … sherherd line totowa nj apartments for rent